Gene · 3326
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epichaperomics reveals dysfunctional chaperone protein networks. | Nat Commun | 2023 | 37607923 | PubTator, text mining | PubMed |
The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation. | Front Genet | 2023 | 37600653 | PubTator, text mining | PubMed |
| Titrating CD47 by mismatch CRISPR-interference reveals incomplete repression can eliminate IgG-opsonized tumors but limits induction of antitumor IgG. | PNAS Nexus | 2023 | 37593202 | PubTator, text mining | PubMed |
| Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha. | Front Immunol | 2023 | 37588598 | PubTator, text mining | PubMed |
| PRM-based quantitative proteomics analysis of altered HSP abundance in villi and decidua of patients with early missed abortion. | Proteome Sci | 2023 | 37587463 | PubTator, text mining | PubMed |
| Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import. | Sci Adv | 2023 | 37585529 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection. | Nutrients | 2023 | 37571380 | PubTator, text mining | PubMed |
| Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma. | Int J Mol Sci | 2023 | 37569852 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Regulating Glutathione Metabolism, Protein-Folding, and Unfolded Protein Response in Pancreatic β-Cells in Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 37569434 | PubTator, text mining | PubMed |
| Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases. | Cells | 2023 | 37566042 | PubTator, text mining | PubMed |
| Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data. | Front Endocrinol (Lausanne) | 2023 | 37564980 | PubTator, text mining | PubMed |
| The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity. | Front Immunol | 2023 | 37564655 | PubTator, text mining | PubMed |
| Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis. | J Extracell Vesicles | 2023 | 37563798 | PubTator, text mining | PubMed |
| Identification of novel immune-related biomarker and therapeutic drugs in Parkinson disease via integrated bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37543820 | PubTator, text mining | PubMed |
| Single-cell trajectory analysis reveals a CD9 positive state to contribute to exit from stem cell-like and embryonic diapause states and transit to drug-resistant states. | Cell Death Discov | 2023 | 37542044 | PubTator, text mining | PubMed |
| Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. | Cell | 2023 | 37541199 | PubTator, text mining | PubMed |
| Multiplex Immunostaining Method to Distinguish HSP Isoforms in Cancer Tissue Specimens. | Methods Mol Biol | 2023 | 37540442 | PubTator, text mining | PubMed |
| Use of Native-PAGE for the Identification of Epichaperomes in Cell Lines. | Methods Mol Biol | 2023 | 37540435 | PubTator, text mining | PubMed |
| Multiple Targeting of HSP Isoforms to Challenge Isoform Specificity and Compensatory Expression. | Methods Mol Biol | 2023 | 37540433 | PubTator, text mining | PubMed |
| Detecting Posttranslational Modifications of Hsp90 Isoforms. | Methods Mol Biol | 2023 | 37540432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3326/papers?page=23